TriSalus Life Sciences (TLSI) Price & Analysis

Compare

64 Followers

TLSI Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.42 - $6.04

Previous CloseN/A

Volume4.84K

Average Volume (3M)56.36K

Market Cap

$138.61M

Enterprise Value$186.47M

Total Cash (Recent Filing)$13.00M

Total Debt (Recent Filing)$33.12M

Price to Earnings (P/E)―

Beta0.77

Next Earnings

Nov 18, 2025

EPS Estimate

-0.15

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.27

Shares Outstanding37,975,815

10 Day Avg. Volume96,437

30 Day Avg. Volume56,363

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.35

Enterprise Value/Revenue5.80

Enterprise Value/Gross Profit6.78

Enterprise Value/Ebitda-8.47

Forecast

1Y Price Target

$10.19

Price Target Upside179.18% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

Bulls Say, Bears Say

Bulls Say

Market AdoptionA new CMS HCPCS code for TriNav Infusion System Mapping is expected to bolster adoption.

Product DevelopmentThe company is preparing to launch TriNav 2.0, which will provide clinicians with a more precise and controlled navigation and placement device.

Revenue GrowthTLSI delivered another solid quarter operationally and reaffirmed revenue guidance of 50%+ in 2025, driven by accelerating sales of TriNav.

Bears Say

Cash Flow ExpectationsInvestments in TriNav commercial efforts have led the company to no longer expect cash flow positivity in FY25, now expected in the first half of 2026.

Financial ReportingThe company plans to delay filing its 10-K for 2024 due to errors in determining stock-based compensation and R&D expense timing.

Gross MarginGross margin came in lower than expected at 84% vs. prior quarters in the upper 80s, stemming from reduced manufacturing related to clean-room expansion.

TriSalus Life Sciences News

TriSalus Life Sciences reports Q2 EPS (27c), consensus (22c)

Reports Q2 revenue $11.2M, consensus $10.69M. “TriSalus continued to deliver strong commercial momentum in the second quarter, underscoring...

2d ago

TLSI

TriSalus Life Sciences backs FY25 revenue growth view up 50%

16:03 EDT TriSalus Life Sciences (TLSI) backs FY25 revenue growth view up 50% Published first on TheFly –...

2d ago

TLSI

TriSalus publishes Pressure-Enabled Drug Delivery technology results

TriSalus Life Sciences (TLSI) announced the publication of clinical data evaluating the use of its proprietary Pressure-Enabled Drug...

3d ago

TLSI

TriSalus Life Sciences Reports Strong Growth Amid Challenges

Trisalus Life Sciences, Inc. (($TLSI)) has held its Q2 earnings call. Read on for the main highlights of...

11h ago

TLSI

TriSalus Life Sciences: Strong Market Adoption and Promising Growth Trajectory with New Product Launches and Revenue Expansion

William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on TriSalus Life Sciences. The associated price...

24h ago

TLSI

TriSalus Life Sciences Reports Strong Q2 2025 Growth

Trisalus Life Sciences, Inc. ( ($TLSI) ) has released its Q2 earnings. Here is a breakdown of the...

1d ago

TLSI

TLSI Earnings this Week: How Will it Perform?

Trisalus Life Sciences, Inc. (TLSI) is scheduled to report 2nd quarter earnings on 08/12/2025, after the market closes....

4d ago

TLSI

TriSalus Completes Exchange Offer for Preferred Stock

TriSalus Life Sciences ( ($TLSI) ) just unveiled an update. TriSalus Life Sciences announced the completion of its...

21d ago

TLSI

TriSalus Launches Exchange Offer for Preferred Stock

TriSalus Life Sciences ( ($TLSI) ) has issued an update. On June 23, 2025, TriSalus Life Sciences announced...

2M ago

TLSI

TriSalus Life Sciences management to meet virtually with Lake Street

Virtual Meeting to be held on June 26 hosted by Lake Street. Published first on TheFly – the...

2M ago

TLSI

TriSalus Life Sciences Holds Annual Shareholder Meeting

TriSalus Life Sciences ( ($TLSI) ) has provided an announcement. On June 12, 2025, TriSalus Life Sciences, Inc....

2M ago

TLSI

Strategic Leadership and Market Developments Drive Buy Rating for TriSalus Life Sciences

Analyst William Plovanic from Canaccord Genuity maintained a Buy rating on TriSalus Life Sciences (TLSI – Research Report)...

2M ago

TLSI

TriSalus Life Sciences files to sell 5.5M shares of common stock for holders

17:00 EDT TriSalus Life Sciences (TLSI) files to sell 5.5M shares of common stock for holders Published first...

3M ago

TLSI

TriSalus Life Sciences Appoints New Chief Financial Officer

TriSalus Life Sciences ( ($TLSI) ) just unveiled an update. On May 30, 2025, TriSalus Life Sciences announced...

3M ago

TLSI

TLSI FAQ

What was TriSalus Life Sciences’s price range in the past 12 months?

TriSalus Life Sciences lowest stock price was $3.42 and its highest was $6.04 in the past 12 months.

What is TriSalus Life Sciences’s market cap?

TriSalus Life Sciences’s market cap is $138.61M.

When is TriSalus Life Sciences’s upcoming earnings report date?

TriSalus Life Sciences’s upcoming earnings report date is Nov 18, 2025 which is in 96 days.

How were TriSalus Life Sciences’s earnings last quarter?

TriSalus Life Sciences released its earnings results on Aug 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.207 by -$0.063.

Is TriSalus Life Sciences overvalued?

According to Wall Street analysts TriSalus Life Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does TriSalus Life Sciences pay dividends?

TriSalus Life Sciences does not currently pay dividends.

What is TriSalus Life Sciences’s EPS estimate?

TriSalus Life Sciences’s EPS estimate is -0.15.

How many shares outstanding does TriSalus Life Sciences have?

TriSalus Life Sciences has 37,975,815 shares outstanding.

What happened to TriSalus Life Sciences’s price movement after its last earnings report?

TriSalus Life Sciences reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.207. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of TriSalus Life Sciences?

Currently, no hedge funds are holding shares in TLSI

TriSalus Life Sciences Stock Smart Score

Underperform

Fundamentals

Return on Equity

271.41%

Trailing 12-Months

Asset Growth

60.01%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

TriSalus Life Sciences

TriSalus Life Sciences (TLSI) is a biotechnology company focused on developing innovative therapies and delivery systems for the treatment of solid tumors. Operating within the pharmaceutical and healthcare sectors, the company specializes in immuno-oncology and drug delivery technologies. Its core offerings include proprietary drug delivery platforms and therapeutic agents designed to enhance the effectiveness of cancer treatments.

TriSalus Life Sciences (TLSI) Earnings & Revenues

Historic Earnings Reports

TLSI Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected strong revenue growth and strategic advancements, particularly in the commercialization of TriNav and preparation for nelitolimod partnerships. However, challenges such as a slight decrease in gross margins and a lack of anticipated positive EBITDA in 2025 were noted.View all TLSI earnings summaries

TLSI Stock 12 Month Forecast

Average Price Target

$10.19

▲(179.18% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","17":"$17","5.75":"$5.75","9.5":"$9.5","13.25":"$13.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.75,9.5,13.25,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.15,5.984615384615385,6.819230769230769,7.653846153846154,8.48846153846154,9.323076923076922,10.157692307692308,10.992307692307692,11.826923076923077,12.661538461538461,13.496153846153845,14.33076923076923,15.165384615384616,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.15,5.537692307692308,5.9253846153846155,6.313076923076923,6.700769230769231,7.088461538461538,7.476153846153846,7.863846153846154,8.25153846153846,8.63923076923077,9.026923076923076,9.414615384615384,9.802307692307693,{"y":10.19,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.15,5.023076923076923,4.8961538461538465,4.769230769230769,4.642307692307693,4.515384615384615,4.388461538461539,4.2615384615384615,4.134615384615385,4.007692307692308,3.880769230769231,3.753846153846154,3.626923076923077,{"y":3.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.33,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.8,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.25,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.32,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.01,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.24,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.01,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.11,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.09,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.21,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.15,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >